Biodegradable polymers for drug delivery systems

Biomedical Polymers

Volumn , Issue , 2007, Pages 83-110

  Kwon, G S ^a   Furgeson, D Y ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DELIVERY SYSTEM;

BIODEGRADABLE POLYMERS;

EID: 77955570354     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845693640.83     Document Type: Chapter

References (173)

1. Ravin H.A., Seligman A.M., Fine J. Polyvinyl pyrrolidone as a plasma expander; studies on its excretion, distribution and metabolism. J Nucl Med 1952, 247(24):921-929.
2. Ammon R., Depner E. Elimination and retention of various polyvinylpyrrolidone types in the body. Z Gesamte Exp Med 1957, 128(6):607-628.
3. Hulme B., Dykes P.W., Appleyard I., Arkell D.W. Retention and storage sites of radioactive polyvinylpyrrolidone. J Nucl Med 1968, 9(7):389-393.
4. Mück K.-F., Christ O., Kellner H.-M. Das Verhalten von isotaktischen Polyacrylsäuren im Organismus. Verteilung und Ausscheidung bei Mäusen. Makromol Chem 1977, 178(10):2785-2797.
5. Azori M., Szinai I., Veres Z., Pato J., Otvos L., Tudos F. Polymeric Prodrugs 3. Synthesis, elimination and whole-body distribution of 14C-labelled drug carrier. Macromol Chem Phys 1986, 187(2):297-302.
6. Bucher J.E., Slade W.C. The anhydrides of isophthalic and terephthalic acids. J Am Chem Soc 1909, 31(12):1319-1321.
7. Leong K.W., Simonte V., Langer R. Synthesis of polyanhydrides: melt-polycondensation, dehydrochlorination, and dehydrative coupling. Macromolecules 1987, 20(4):705-712.
8. Lundmark S., Sjoling M., Albertsson A.C. Polymerization of oxepan-2,7-dione in solution and synthesis of block copolymers of oxepan-2,7-dione and 2-oxepanone. J Macromol Sci Part A: Pure Appl Chem 1991, 28(1):15-29.
9. Domb A.J., Langer R. Polyanhydrdies 1. Preparation of high-molecular-weight polyanhydrides. J Polym Sci Part A: Polym Chem 1987, 25(12):3373-3386.
10. Rosen H.B., Chang J., Wnek G.E., Linhardt R.J., Langer R. Bioerodible polyanhydrides for controlled drug delivery. Biomaterials 1983, 4(2):131-133.
11. Leong K.W., Brott B.C., Langer R. Bioerodible polyanhydrides as drug-carrier matrices. I. Characterization, degradation and release characteristics. J Biomed Mater Res 1985, 19(8):941-955.
12. Leong K.W., D'amore P.D., Marletta M., Langer R. Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. J Biomed Mater Res 1986, 20(1):51-64.
13. D'emanuele A., Hill J., Tamada J.A., Domb A.J., Langer R. Molecular weight changes in polymer erosion. Pharm Res 1992, 9(10):1279-1283.
14. Park M.C., Weaver C.E.J., Donahue J.E., Sampath P. Intracavitary chemotherapy (Gliadel) for recurrent esthesioneuroblastoma: case report and review of the literature. J Neurooncol 2006, 77(1):47-51.
15. Shikanov A., Domb A.J. Poly(sebacic acid-co-ricinoleic acid) biodegradable injectable in situ gelling polymer. Biomacromolecules 2006, 7(1):288-296.
16. Shikanov A., Vaisman B., Krasko M.Y., Nyska A., Domb A.J. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity. J Biomed Mater Res Part A 2004, 69(1):47-54.
17. Furtado S., Abramson D., Simhkay L., Wobbekind D., Mathiowitz E. Subcutaneous delivery of insulin loaded poly(fumaric-co-sebacic anhydride) microspheres to type 1 diabetic rats. Eur J Pharm Biopharm 2006, 63(2):229-236.
18. Couvreur P., Kante B., Roland M., Guiot P., Bauduin P., Speiser P. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J Pharm Pharmacol 1979, 31(5):331-332.
19. Couvreur P., Kante B., Roland M., Speiser P. Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum. J Pharm Sci 1979, 68(12):1521-1524.
20. Andrieu V., Fessi H., Dubrasquet M., Devissaguet J.P., Puisieux F., Benita S. Pharmacokinetic evaluation of indomethacin nanocapsules. Drug Des Deliv 1989, 4(4):295-302.
21. Polato L., Benedetti L.M., Callegaro L., Couvreur P. In vitro evaluation of nanoparticle formulations containing gangliosides. J Drug Target 1994, 2(1):53-59.
22. Godard G., Boutorine A.S., Saison-Behmoaras E., Helene C. Antisense effects of cholesterol-oligodeoxynucleotide conjugates associated with poly(alkylcyanoacrylate) nanoparticles. Eur J Biochem 1995, 232(2):404-410.
23. Fresta M., Cavallaro G., Giammona G., Wehrli E., Puglisi G. Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs. Biomaterials 1996, 17(8):751-758.
24. Aboubakar M., Puisieux F., Couvreur P., Deyme M., Vauthier C. Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. J Biomed Mater Res 1999, 47(4):568-576.
25. Boudad H., Legrand P., Lebas G., Cheron M., Duchene D., Ponchel G. Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir. Int J Pharm 2001, 218(1-2):113-124.
26. Chauvierre C., Marden M.C., Vauthier C., Labarre D., Couvreur P., Leclerc L. Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier. Biomaterials 2004, 25(15):3081-3086.
27. Hillaireau H., Le Doan T., Couvreur P. Polymer-based nanoparticles for the delivery of nucleoside analogues. J Nanosci Nanotechnol 2006, 6(9-10):2608-2617.
28. Lherm C., Muller R.H., Puisieux F., Couvreur P. Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length. Int J Pharm 1992, 84(1):13-22.
29. Muller R.H., Lherm C., Herbort J., Couvreur P. In vitro model for the degradation of alkylcyanoacrylate nanoparticles. Biomaterials 1990, 11(8):590-595.
30. Peracchia M.T., Vauthier C., Desmaele D., Gulik A., Dedieu J.C., Demoy M., D'angelo J., Couvreur P. PEGylated nanoparticles from a novel methoxy-polyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer. Pharm Res 1998, 15(4):550-556.
31. Peracchia M.T., Vauthier C., Puisieux F., Couvreur P. Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol). J Biomed Mater Res 1997, 34(3):317-326.
32. Stella B., Arpicco S., Peracchia M.T., Desmaele D., Hoebeke J., Renoir M., D'angelo J., Cattel L., Couvreur P. Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci 2000, 89(11):1452-1464.
33. Peracchia M.T., Fattal E., Desmaele D., Besnard M., Noel J.P., Gomis J.M., Appel M., D'angelo J., Couvreur P. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Release 1999, 60(1):121-128.
34. Crommen J.H., Schacht E.H., Mense E.H. Biodegradable polymers. II. Degradation characteristics of hydrolysis-sensitive poly[(organo)phosphazenes]. Biomaterials 1992, 13(9):601-611.
35. Singh A., Krogman N.R., Sethuraman S., Nair L.S., Sturgeon J.L., Brown P.W., Laurencin C.T., Allcock H.R. Effect of side group chemistry on the properties of biodegradable l-alanine cosubstituted polyphosphazenes. Biomacromolecules 2006, 7(3):914-918.
36. Allcock H.R., Kugel R.L. Synthesis of high polymeric alkoxy- and aryloxy-phosphonitriles. J Am Chem Soc 1965, 87(18):4216-4217.
37. Allcock H.R., Singh A., Ambrosio A.M., Laredo W.R. Tyrosine-bearing polyphosphazenes. Biomacromolecules 2003, 4(6):1646-1653.
38. Caliceti P., Lora S., Marsilio F., Veronese F.M. Preparation and characterisation of polyphosphazene-based controlled release systems for naproxen. Farmaco 1995, 50(12):867-874.
39. Veronese F.M., Marsilio F., Lora S., Caliceti P., Passi P., Orsolini P. Polyphosphazene membranes and microspheres in periodontal diseases and implant surgery. Biomaterials 1999, 20(1):91-98.
40. Allcock H.R., Pucher S.R., Scopelianos A.G. Poly[(amino acid ester)phosphazenes] as substrates for the controlled release of small molecules. Biomaterials 1994, 15(8):563-569.
41. De Scheerder I.K., Wilczek K.L., Verbeken E.V., Vandorpe J., Lan P.N., Schacht E., De Geest H., Piessens J. Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. Atherosclerosis 1995, 114(1):105-114.
42. Allcock H.R. Inorganic-organic polymers as a route to biodegradable materials. Macromol Symp 1999, 144:33-46.
43. Neenan T.X., Allcock H.R. Synthesis of a heparinized poly(organophosph azene). Biomaterials 1982, 3(2):78-80.
44. Zhang J.X., Qiu L.Y., Jin Y., Zhu K.J. Physicochemical characterization of polymeric micelles constructed from novel amphiphilic polyphosphazene with poly(N-isopropylacrylamide) and ethyl 4-aminobenzoate as side groups. Colloids Surf B: Biointerfaces 2005, 43(3-4):123-130.
45. Allcock H.R., Kwon S., Riding G.H., Fitzpatrick R.J., Bennett J.L. Hydrophilic polyphosphazenes as hydrogels: radiation cross-linking and hydrogel characteristics of poly[bis(methoxyethoxyethoxy)phosphazene]. Biomaterials 1988, 9(6):509-513.
46. Allcock H.R., Neenan T.X., Kossa W.C. Coupling of cyclic and high polymeric aminoaryloxyphosphazenes to carboxylic acids: prototypes for bioactive polymers. Macromolecules 1982, 15(3):693-696.
47. Allcock H.R., Scopelianos A.G. Synthesis of sugar-substituted cyclic and polymeric phosphazenes and their oxidation, reduction, and acetylation reactions. Macromolecules 1983, 16(5):715-719.
48. Laurencin C.T., Koh H.J., Neenan T.X., Allcock H.R., Langer R. Controlled release using a new bioerodible polyphosphazene matrix system. J Biomed Mater Res 1987, 21(10):1231-1246.
49. Veronese F.M., Marsilio F., Caliceti P., De Filippis P., Giunchedi P., Lora S. Polyorganophosphazene microspheres for drug release: polymer synthesis, microsphere preparation, in vitro and in vivo naproxen release. J Control Release 1998, 52(3):227-237.
50. Luten J., Van Steenis J.H., Van Someren R., Kemmink J., Schuurmans-Nieuwenbroek N.M., Koning G.A., Crommelin D.J., Van Nostrum C.F., Hennink W.E. Water-soluble biodegradable cationic polyphosphazenes for gene delivery. J Control Release 2003, 89(3):483-497.
51. Crommen J.H., Schacht E.H., Mense E.H. Biodegradable polymers. I. Synthesis of hydrolysis-sensitive poly[(organo)phosphazenes]. Biomaterials 1992, 13(8):511-520.
52. Aldini N.N., Caliceti P., Lora S., Fini M., Giavaresi G., Rocca M., Torricelli P., Giardino R., Veronese F.M. Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation. J Orthop Res 2001, 19(5):955-961.
53. Ibim S.M., El-Amin S.F., Goad M.E., Ambrosio A.M., Allcock H.R., Laurencin C.T. In vitro release of colchicine using poly(phosphazenes): the development of delivery systems for musculoskeletal use. Pharm Dev Technol 1998, 3(1):55-62.
54. Song S.C., Soo Sohn Y. Synthesis and hydrolytic properties of polyphosphazene/(diamine)platinum/saccharide conjugates. J Control Release 1998, 55(2-3):161-170.
55. Song R., Joo Jun Y., Ik Kim J., Jin C., Sohn Y.S. Synthesis, characterization and tumor selectivity of a polyphosphazene-platinum(II) conjugate. J Control Release 2005, 105(1-2):142-150.
56. Caliceti P., Veronese F.M., Lora S. Polyphosphazene microspheres for insulin delivery. Int J Pharm 2000, 211(1-2):57-65.
57. Andrianov A.K., Marin A., Roberts B.E. Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity. Biomacromolecules 2005, 6(3):1375-1379.
58. Seong J.Y., Jun Y.J., Kim B.M., Park Y.M., Sohn Y.S. Synthesis and characterization of biocompatible poly(organophosphazenes) aiming for local delivery of protein drugs. Int J Pharm 2006, 314(1):90-96.
59. Huang Y., Liu X., Wang L., Verbeken E., Li S., De Scheerder I. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model. Int J Cardiovasc Intervent 2003, 5(3):166-171.
60. Wang L., Salu K., Verbeken E., Bosmans J., Van De Werf F., De Scheerder I., Huang Y. Stent-mediated methylprednisolone delivery reduces macrophage contents and in-stent neointimal formation. Coron Artery Dis 2005, 16(4):237-243.
61. Huang Y., Salu K., Liu X., Li S., Wang L., Verbeken E., Bosmans J., De Scheerder I. Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model. Heart 2004, 90(2):195-199.
62. Huang Y., Salu K., Wang L., Liu X., Li S., Lorenz G., Wnendt S., Verbeken E., Bosmans J., Van De Werf F., De Scheerder I. Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model. J Invasive Cardiol 2005, 17(3):142-148.
63. Huang Y., Wang L., Li S., Liu X., Lee K., Verbeken E., Van De Werf F., De Scheerder I. Stent-based tempamine delivery on neointimal formation in a porcine coronary model. Acute Card Care 2006, 8(4):210-216.
64. Kawakami H., Kanezaki S., Sudo M., Kanno M., Nagaoka S., Kubota S. Biodegradation and biocompatibility of polyorganophosphazene. Artif Organs 2002, 26(10):883-890.
65. Caliceti P., Nicoli Aldini N., Fini M., Rocca M., Gnudi S., Lora S., Giavaresi G., Monfardini C., Giardino R., Veronese F.M. Bioabsorbable polyphosphazene matrices as systems for calcitonin controlled release. Farmaco 1997, 52(11):697-702.
66. De Scheerder I.K., Wilczek K.L., Verbeken E.V., Vandorpe J., Lan P.N., Schacht E., Piessens J., De Geest H. Biocompatibility of biodegradable and non-biodegradable polymer-coated stents implanted in porcine peripheral arteries. Cardiovasc Intervent Radiol 1995, 18(4):227-232.
67. Huang Y., Liu X., Wang L., Li S., Verbeken E., De Scheerder I. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model. Coron Artery Dis 2003, 14(5):401-408.
68. Lapienis G., Penczek S. Toward nucleic-acid like backbones by ionic polymerizations-kinetics and thermodynamics of polymerization of cyclic phosphate esters. 2. Cationic polymerization of 2-methoxy-2-oxo-1,3,2-dioxaphosphorinane 1,3-propylene methyl phosphate. Macromolecules 1974, 7(2):166-174.
69. Qiu J.J., Liu C.M., Hu F., Guo X.D., Zheng Q.X. Synthesis of unsaturated polyphosphoester as a potential injectable tissue engineering scaffold material. J Appl Polym Sci 2006, 102(4):3095-3101.
70. Sen Gupta A., Lopina S.T. Synthesis and characterization of L-tyrosine based novel polyphosphates for potential biomaterial applications. Polymer 2004, 45(14):4653-4662.
71. Chaubal M.V., Wang B., Su G., Zhao Z. Compositional analysis of biodegradable polyphosphoester copolymers using NMR spectroscopic methods. J Appl Polym Sci 2003, 90(14):4021-4031.
72. Wang J., Zhuo R.X. Synthesis and characterization of phosphoester linkage-containing hydrogels. Eur Polym J 1999, 35(3):491-497.
73. Xiao C.S., Wang Y.C., Du J.Z., Chen X.S., Wang J. Kinetics and mechanism of 2-ethoxy-2-oxo-1,3,2-dioxaphospholane polymerization initiated by stannous octoate. Macromolecules 2006, 39(20):6825-6831.
74. Wang J., Zhang P.C., Mao H.Q., Leong K.W. Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier. Gene Ther 2002, 9(18):1254-1261.
75. Wang J., Mao H.Q., Leong K.W. A novel biodegradable gene carrier based on polyphosphoester. J Am Chem Soc 2001, 123(38):9480-9481.
76. Huang S.W., Wang J., Zhang P.C., Mao H.Q., Zhuo R.X., Leong K.W. Water-soluble and nonionic polyphosphoester: synthesis, degradation, biocompatibility and enhancement of gene expression in mouse muscle. Biomacromolecules 2004, 5(2):306-311.
77. Wen J., Mao H.Q., Li W., Lin K.Y., Leong K.W. Biodegradable polyphosphoester micelles for gene delivery. J Pharm Sci 2004, 93(8):2142-2157.
78. Mao H.Q., Leong K.W. Design of polyphosphoester-DNA nanoparticles for non-viral gene delivery. Adv Genet 2005, 53:275-306.
79. Xu X., Yu H., Gao S., Ma H.Q., Leong K.W., Wang S. Polyphosphoester microspheres for sustained release of biologically active nerve growth factor. Biomaterials 2002, 23(17):3765-3772.
80. Mao H.Q., Shipanova-Kadiyaia I., Zhao Z., Dang W., Leong K.W. Encyclopedia of Controlled Drug Delivery 1999, Wiley, New York.
81. Harper E., Dang W., Lapidus R.G., Garver R.I.J. Enhanced efficacy of a novel controlled release paclitaxel formulation (Paclimer delivery system) for local-regional therapy of lung cancer tumor nodules in mice. Clin Cancer Res 1999, 5(12):4242-4248.
82. Li K.W., Dang W., Tyler B.M., Troiano G., Tihan T., Brem H., Walter K.A. Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies. Clin Cancer Res 2003, 9(9):3441-3447.
83. Pradilla G., Wang P.P., Gabikian P., Li K., Magee C.A., Walter K.A., Brem H. Local intracerebral administration of paclitaxel with the paclimer delivery system: toxicity study in a canine model. J Neurooncol 2006, 76(2):131-138.
84. Lapidus R.G., Dang W., Rosen D.M., Gady A.M., Zabelinka Y., O'meally R., Deweese T.L., Denmeade S.R. Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (Paclimer microspheres) and radiation. Prostate 2004, 58(3):291-298.
85. Armstrong D.K., Fleming G.F., Markman M., Bailey H.H. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2006, 103(2):391-396.
86. Grigat E., Koch R., Timmermann R. BAK 1095 and BAK 2195: coompletely biodegradable synthetic thermoplastics. Polym Degrad Stab 1998, 59(1-3):223-226.
87. Carothers W.H. Studies on polymerization and ring formation. I. An introduction to the general theory of condensation polymers. J Am Chem Soc 1929, 51(8):2548-2559.
88. Carothers W.H., Arvin J.A. Studies on polymerization and ring formation. II. Polyesters. J Am Chem Soc 1929, 51(8):2560-2570.
89. Cutright D.E., Perez B., Beasley J., Larson W.J., Posey W.R. Degradation rates of polymers and copolymers of polylactic and polyglycolic acids. Oral Surg Oral Med Oral Pathol 1974, 37(1):142-152.
90. Kronenthal R.L., Oser Z., Martin E. Polymers in Medicine and Surgery 1975, Plenum, New York.
91. Middleton J.C., Tipton A.J. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 2000, 21(23):2335-2346.
92. Brode G.L., Koleske J.V. Lactone polymerization and polymer properties. J Macromol Sci Part A: Pure Appl Chem 1972, 6(6):1109-1144.
93. Horlbeck G., Siesler H.W., Tittle B. Characterization of polyether and polyester homopolymers and copolymers prepared by ring-opening polymerization with a new catalytic system. Macromolecules 1977, 10(2):284-287. GT.
94. Kricheldorf H.R., Berl M., Scharnagl N. Poly(lactones). 9. Polymerization mechanism of metal alkoxide initiated polymerizations of lactide and various lactones. Macromolecules 1988, 21(2):286-293.
95. Bailey W.J., Ni Z., Wu S.R. Synthesis of poly-epsilon-caprolactone via a free-radical mechanism - free-radical ring-opening polymerization of 2-methylene-1,3-dioxepane. J Polym Sci Part A: Polym Chem 1982, 20(11):3021-3030.
96. Forrest M.L., Zhao A., Won C.Y., Malick A.W., Kwon G.S. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-β-poly(epsilon-caprolactone) micelles. J Control Release 2006, 116(2):139-149.
97. Forrest M.L., Won C.Y., Malick A.W., Kwon G.S. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-β-poly(epsilon-caprolactone) micelles. J Control Release 2006, 110(2):370-377.
98. Cohn D., Salomon A.H. Designing biodegradable multiblock PCL/PLA thermoplastic elastomers. Biomaterials 2005, 26(15):2297-2305.
99. Jo S., Kim J., Kim S.W. Reverse thermal gelation of aliphatically modified biodegradable triblock copolymers. Macromol Biosci 2006, 6(11):923-928.
100. Chung T.W., Liu D.Z., Hsieh J.H., Fan X.C., Yang J.D., Chen J.H. Characterizing poly(epsilon-caprolactone)-β-chitooligosaccharide-β-poly(ethylene glycol) (PCP) copolymer micelles for doxorubicin (DOX) delivery: effects of crosslinked of amine groups. J Nanosci Nanotechnol 2006, 6(9-10):2902-2911.
101. Timbart L., Renard E., Langlois V., Guerin P. Novel biodegradable copolyesters containing blocks of poly(3-hydroxyoctanoate) and poly(epsilon-caprolactone): synthesis and characterization. Macromol Biosci 2004, 4(11):1014-1020.
102. Nakayama M., Okano T., Miyazaki T., Kohori F., Sakai K., Yokoyama M. Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. J Control Release 2006, 115(1):46-56.
103. Research Triangle Institute Capronor. Hypotenuse 1985, 2-5. May-June.
104. Aliabadi H.M., Mahmud A., Sharifabadi A.D., Lavasanifar A. Micelles of methoxy poly(ethylene oxide)-β-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A. J Control Release 2005, 104(2):301-311.
105. Aliabadi H.M., Brocks D.R., Lavasanifar A. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution. Biomaterials 2005, 26(35):7251-7259.
106. Vandermeulen G., Rouxhet L., Arien A., Brewster M.E., Preat V. Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles. Int J Pharm 2006, 309(1-2):234-240.
107. Vakil R., Kwon G.S. Poly(ethylene glycol)-β-poly(epsilon-caprolactone) and PEG-phospholipid form stable mixed micelles in aqueous media. Langmuir 2006, 22(23):9723-9729.
108. Allen C., Han J., Yu Y., Maysinger D., Eisenberg A. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J Control Release 2000, 63(3):275-286.
109. Kim S.Y., Shin I.G., Lee Y.M., Cho C.S., Sung Y.K. Methoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours. J Control Release 1998, 51(1):13-22.
110. Shin I.G., Kim S.Y., Lee Y.M., Cho C.S., Sung Y.K. Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. J Control Release 1998, 51(1):1-11.
111. Cheon Lee S., Kim C., Chan Kwon I., Chung H., Young Jeong S. Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. J Control Release 2003, 89(3):437-446.
112. Katz A.R., Turner R.J. Evaluation of tensile and absorption properties of polyglycolic acid sutures. Surg Gynecol Obstet 1970, 131(4):701-716.
113. Lim Y., Kim C., Kim K., Kim S.W., Park J. Development of a safe gene delivery system using biodegradable polymer, poly[α-(4-aminobutyl)-l-glycolic acid]. J Am Chem Soc 2000, 122(27):6524-6525.
114. Lim Y.B., Han S.O., Kong H.U., Lee Y., Park J.S., Jeong B., Kim S.W. Biodegradable polyester, poly[α-(4-aminobutyl)-l-glycolic acid], as a nontoxic gene carrier. Pharm Res 2000, 17(7):811-816.
115. Lim Y.B., Kim S.M., Suh H., Park J.S. Biodegradable, endosome disruptive and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier. Bioconjug Chem 2002, 13(5):952-957.
116. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., Labhasetwar V. Rapid endolysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 2002, 16(10):1217-1226.
117. Denis-Mize K.S., Dupuis M., Mackichan M.L., Singh M., Doe B., O'hagan D., Ulmer J.B., Donnelly J.J., Mcdonald D.M., Ott G. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther 2000, 7(24):2105-2112.
118. Li Z., Ning W., Wang J., Choi A., Lee P.Y., Tyagi P., Huang L. Controlled gene delivery system based on thermosensitive biodegradable hydrogel. Pharm Res 2003, 20(6):884-888.
119. Putnam D., Langer R. Poly(4-hydroxy-l-proline ester): low-temperature polycondensation and plasmid DNA complexation. Macromolecules 1999, 32(11):3658-3662.
120. Lim Y., Choi Y.H., Park J. A self-destroying polycationic polymer: biodegradable poly(4-hydroxy-l-proline ester). J Am Chem Soc 1999, 121(24):5633-5639.
121. Chu C.C. An in vitro study of the effect of buffer on the degradation of poly(glycolic acid) sutures. J Biomed Mater Res 1981, 15(1):19-27.
122. Chu C.C. The in vitro degradation of poly(glycolic acid) sutures - effect of pH. J Biomed Mater Res 1981, 15(6):795-804.
123. Chu C.C. Hydrolytic degradation of polyglycolic acid - tensile-strength and crystallinity study. J Appl Polym Sci 1981, 26(5):1727-1734.
124. Gilding K. Biodegradable polymers. Biocompatibility of Clinical Implant Materials 1981, Vol II:209-232. CRC Press, Boca Raton, Florida. D.F. Williams (Ed.).
125. Hollinger J.O. Preliminary report on the osteogenic potential of a biodegradable copolymer of polyactide (PLA) and polyglycolide (PGA). J Biomed Mater Res 1983, 17(1):71-82.
126. Williams D.F., Mort E. Enzyme-accelerated hydrolysis of polyglycolic acid. J Bioeng 1977, 1(3):231-238.
127. Koh J.J., Ko K.S., Lee M., Han S., Park J.S., Kim S.W. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice. Gene Ther 2000, 7(24):2099-2104.
128. Lee M., Ko K.S., Oh S., Kim S.W. Prevention of autoimmune insulitis by delivery of a chimeric plasmid encoding interleukin-4 and interleukin-10. J Control Release 2003, 88(2):333-342.
129. Ko K.S., Lee M., Koh J.J., Kim S.W. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. Mol Ther 2001, 4(4):313-316.
130. Ignatius A.A., Claes L.E. In vitro biocompatibility of bioresorbable polymers: poly(l, dl-lactide) and poly(l-lactide-co-glycolide). Biomaterials 1996, 17(8):831-839.
131. Steendam R., Van Steenbergen M.J., Hennink W.E., Frijlink H.W., Lerk C.F. Effect of molecular weight and glass transition on relaxation and release behaviour of poly(dl-lactic acid) tablets. J Control Release 2001, 70(1-2):71-82.
132. Ikada Y., Jamshidi K., Tsuji H., Hyon S.-H. Stereocomplex formation between enantiomeric poly(lactides). Macromolecules 1987, 20(4):904-906.
133. Vert M. Bioresorbable polymers for temporary therapeutic applications. Angew Makromol Chem February 1989, 166:155-168.
134. Gunatillake P.A., Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater J 2003, 5:1-16. discussion, 16.
135. Nair L.S., Laurencin C.T. Polymers as biomaterials for tissue engineering and controlled drug delivery. Adv Biochem Eng Biotechnol October 2006, 102:47-90.
136. Helder J., Kohn F.E., Sato S., Vandenberg J.W., Feijen J. Synthesis of poly[oxyethylidenecarbonylimino-(2-oxoethylene)] [poly(glycine-d,l-lactic acid)] by ring-opening polymerization. Makromol Chem, Rapid Commun 1985, 6(1):9-14.
137. Helder J., Feijen J., Lee S.J., Kim S.W. Copolymers of d,l-lactic acid and glycine. Makromol Chem, Rapid Commun 1986, 7(4):193-198.
138. Astete C.E., Sabliov C.M. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci, Polym Edn 2006, 17(3):247-289.
139. Gilding D.K., Reed A.M. Biodegradable polymers for use in surgery - polyglycolic/poly(actic acid) homo- and copolymers: 1. Polymer 1979, 20(12):1459-1464.
140. Reed A.M., Gilding D.K. Biodegradable polymers for use in surgery - poly(glycolic)/poly(lactic acid) homo and copolymers: 2. In vitro degradation. Polymer 1981, 22(4):494-498.
141. Miller R.A., Brady J.M., Cutright D.E. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. J Biomed Mater Res 1977, 11(5):711-719.
142. Jiang W., Gupta R.K., Deshpande M.C., Schwendeman S.P. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 2005, 57(3):391-410.
143. Bala I., Hariharan S., Kumar M.N. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 2004, 21(5):387-422.
144. Panyam J., Labhasetwar V. Targeting intracellular targets. Curr Drug Deliv 2004, 1(3):235-247.
145. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003, 55(3):329-347.
146. Taylor M.S., Daniels A.U., Andriano K.P., Heller J. Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J Appl Biomater 1994, 5(2):151-157.
147. Hsu Y.Y., Hao T., Hedley M.L. Comparison of process parameters for microencapsulation of plasmid DNA in poly(d,l-lactic-co-glycolic) acid microspheres. J Drug Target 1999, 7(4):313-323.
148. Walter E., Moelling K., Pavlovic J., Merkle H.P. Microencapsulation of DNA using poly(dl-lactide-co-glycolide): stability issues and release characteristics. J Control Release 1999, 61(3):361-374.
149. Wang C., Ge Q., Ting D., Nguyen D., Shen H.R., Chen J., Eisen H.N., Heller J., Langer R., Putnam D. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater 2004, 3(3):190-196.
150. Gerweck L.E., Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 1996, 56(6):1194-1198.
151. Choi N.S., Heller J. Erodible agent releasing device comprising poly(ortho esters) and poly(ortho carbonates) 1979, Alza Corporation, US Pat 4,138,344.
152. Choi N.S., Heller J. Novel ortho ester polymers and orthocarbonate polymers 1979, Alza Corporation, US Pat 4,180,646.
153. Choi N.S., Heller J. Polycarbonates 1978, Alza Corporation, US Pat 4,079,038.
154. Choi N.S., Heller J. Drug delivery devices manufactured from poly(ortho esters) and poly(ortho carbonates) 1978, Alza Corporation, US Pat 4,093,709.
155. Choi N.S., Heller J. Structured ortho ester and ortho carbonate delivery devices 1978, Alza Corporation, US Pat 4,131,648.
156. Yang K.K., Wang X.L., Wang Y.Z. Poly(p-dioxanone) and its copolymers. J Macromol Sci 2002, 42(3):373-398.
157. Schappacher M., Fabre T., Mingotaud A.F., Soum A. Study of a (trimethylenecarbonate-co-epsilon-caprolactone) polymer. Part 1: preparation of a new nerve guide through controlled random copolymerization using rare earth catalysts. Biomaterials 2001, 22(21):2849-2855.
158. Katz A.R., Mukherjee D.P., Kaganov A.L., Gordon S. A new synthetic monofilament absorbable suture made from polytrimethylene carbonate. Surg Gynecol Obstet 1985, 161(3):213-222.
159. Ahn C.H., Chae S.Y., Bae Y.H., Kim S.W. Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release 2002, 80(1-3):273-282.
160. Petersen H., Merdan T., Kunath K., Fischer D., Kissel T. Poly(ethylenimine-co-l-lactamide-co-succinamide): a biodegradable polyethylenimine derivative with an advantageous pH-dependent hydrolytic degradation for gene delivery. Bioconjug Chem 2002, 13(4):812-821.
161. Forrest M.L., Koerber J.T., Pack D.W. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug Chem 2003, 14(5):934-940.
162. Kim Y.H., Park J.H., Lee M., Kim Y.H., Park T.G., Kim S.W. Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J Control Release 2005, 103(1):209-219.
163. Thomas M., Ge Q., Lu J.J., Chen J., Klibanov A.M. Cross-linked small polyethylenimines: while still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo. Pharm Res 2005, 22(3):373-380.
164. Park M.R., Han K.O., Han I.K., Cho M.H., Nah J.W., Choi Y.J., Cho C.S. Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control Release 2005, 105(3):367-380.
165. Zhong Z., Feijen J., Lok M.C., Hennink W.E., Christensen L.V., Yockman J.W., Kim Y.H., Kim S.W. Low molecular weight linear polyethylenimine-β-poly(ethylene glycol)-β-polyethylenimine triblock copolymers: synthesis, characterization and in vitro gene transfer properties. Biomacromolecules 2005, 6(6):3440-3448.
166. Bikram M., Lee M., Chang C.W., JanÁT M.M., Kern S.E., Kim S.W. Long-circulating DNA-complexed biodegradable multiblock copolymers for gene delivery: degradation profiles and evidence of dysopsonization. J Control Release 2005, 103(1):221-233.
167. Bikram M., Ahn C.H., Chae S.Y., Lee M.Y., Yockman J.W., Kim S.W. Biodegradable poly(ethylene glycol)-co-poly(l-lysine)-γ-histidine multiblock copolymers for nonviral gene delivery. Macromolecules 2004, 37(5):1903-1916.
168. Anderson J.M., Spilizewski K.L., Hiltner A. Poly-α-amino acids as biomedical polymers. Biocompatibility of Tissue Analogs 1985, 67-88. CRC Press, Boca Raton, Florida. D.F. Williams (Ed.).
169. Perin E.C. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS. Rev Cardiovasc Med 2005, 6(Suppl 1):S13-S21.
170. Kohn J., Zeltinger J. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease. Expert Rev Med Devices 2005, 2(6):667-671.
171. Westedt U., Wittmar M., Hellwig M., Hanefeld P., Greiner A., Schaper A.K., Kissel T. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings. J Control Release 2006, 111(1-2):235-246.
172. Sharif F., Hynes S.O., Mcmahon J., Cooney R., Conroy S., Dockery P., Duffy G., Daly K., Crowley J., Bartlett J.S., O'brien T. Gene-eluting stents: comparison of adenoviral and adeno-associated viral gene delivery to the blood vessel wall in vivo. Hum Gene Ther 2006, 17(7):741-750.
173. Jewell C.M., Zhang J., Fredin N.J., Wolff M.R., Hacker T.A., Lynn D.M. Release of plasmid DNA from intravascular stents coated with ultrathin multilayered polyelectrolyte films. Biomacromolecules 2006, 7(9):2483-2491.